BMY Competitors & Rivals
Compare Bristol-Myers Squibb Company with top Drug Manufacturers - General companies
Bristol-Myers Squibb Company
BMY - Healthcare
Market Cap
$95.4B
Price
$56.70
P/E Ratio
17.49
Revenue Growth
N/A
Top Competitors
Side-by-Side Comparison
| Metric | BMY | AAPL | MSFT | GOOGL |
|---|---|---|---|---|
| Price | $56.70 | $312.66 | $386.74 | $366.46 |
| Market Cap | $95.4B | $3829.7B | $3707.6B | $2971.3B |
| P/E Ratio | 17.49 | 39.16 | 38.61 | 26.13 |
| Revenue Growth | N/A | N/A | N/A | N/A |
| Profit Margin | N/A | N/A | N/A | N/A |
Detailed Head-to-Head Comparisons
Get in-depth analysis comparing BMY with each competitor
Frequently Asked Questions
Who are BMY's main competitors?
BMY's main competitors include AAPL, MSFT, GOOGL, and other companies in the Drug Manufacturers - General industry. These companies compete directly with Bristol-Myers Squibb Company for market share and customers.
How does BMY compare to its competitors?
BMY can be compared to competitors using metrics like market capitalization, P/E ratio, revenue growth, profit margins, and market share. Each competitor has different strengths - some may have better valuations while others have higher growth rates.
What are the best alternatives to BMY stock?
The best alternatives to BMY depend on your investment goals. For similar market exposure, consider AAPL or MSFT. For different risk profiles, research companies with varying market caps and growth trajectories in the Drug Manufacturers - General sector.
Which is better: BMY or AAPL?
Comparing BMY vs AAPL requires analyzing valuation metrics, growth prospects, competitive advantages, and risk factors. Neither is universally "better" - the right choice depends on your investment strategy, risk tolerance, and market outlook.
What makes BMY different from its competitors?
Bristol-Myers Squibb Company differentiates itself through its unique business model, product offerings, market positioning, and competitive advantages. Factors like brand strength, innovation, operational efficiency, and financial health distinguish BMY from rivals.
Should I diversify across BMY and its competitors?
Diversifying across multiple companies in the same industry can reduce company-specific risk while maintaining sector exposure. However, this doesn't eliminate sector risk. Consider diversifying across different industries and sectors for better risk-adjusted returns.
Continue Your Research
Explore more analysis tools for BMY